Page 94 - 《中国药房》2023年21期
P. 94

腹膜透析患者全程智慧化药学服务模式的建立
                                                                                  Δ


                                                                                     1
                                           4
                                                            6
                                                    5
                                   3
                                                                            7
                 1*
                                                                    6
          杭永付 ,徐 燕 ,戴小花 ,吴甜甜 ,段银银 ,徐德宇 ,胡 坤 ,刘星星 ,朱建国 ,缪丽燕 ,李 琳 (1.苏州
                                                                                                     6 #
                                                                                             1
                           2
          大学附属第一医院药学部,江苏 苏州 215006;2.郑州大学第五附属医院药学部,郑州 450052;3.肇庆市第一
          人民医院药学部,广东 肇庆 526000;4.郑州大学附属郑州中心医院药学部,郑州 450007;5.淮安市第一人民
          医院药学部,江苏 淮安 223300;6.苏州大学附属第一医院肾内科,江苏 苏州 215006;7.贵阳市妇幼保健院
          药剂科,贵阳 550003)
          中图分类号  R952      文献标志码  A      文章编号  1001-0408(2023)21-2644-05
          DOI  10.6039/j.issn.1001-0408.2023.21.13
          摘   要  目的  建立腹膜透析(PD)全程智慧化药学服务模式,为临床药师提供规范化PD药学服务提供参考。方法  调研分析国
          内外PD患者的药学服务模式,结合苏州大学附属第一医院(以下简称“我院”)实际情况,以“居家→PD中心门诊→住院部”为主要
          节点,优化药物重整循环流程。通过改良汉化版的药物相关问题(DRPs)分类工具,制定相应的药学服务流程,展示具体案例等方
          面阐述 PD 全程智慧化药学服务模式。结果  我院以药物治疗管理(MTM)平台为依托,构建了“在院药学监护(建档)-PD 门诊
          MTM-居家药学服务(线上App管理)”的闭环PD全程智慧化药学服务模式,形成了“入院→出院→门诊”药物重整循环和“发现-分
          析-干预-随访-记录-评估”DRPs循环的“双循环”工作流程。结论  我院PD全程智慧化药学服务模式的建立为规范PD患者的药学
          服务提供了经验,可以减少DRPs。
          关键词  腹膜透析;药学服务;工作模式;临床药师;药物重整;药物相关问题;药物治疗管理

          Establishment of whole-process intelligent pharmaceutical care model for peritoneal dialysis patients
                                                           4
                       1
                                                                          5
                                                                                    6
                                              3
          HANG Yongfu ,XU Yan ,DAI Xiaohua ,WU Tiantian ,DUAN Yinyin ,XU Deyu ,HU Kun ,LIU Xingxing ,
                                                                                             6
                                2
                                                                                                            7
          ZHU Jianguo ,MIAO Liyan ,LI Lin(1. Dept. of Pharmacy, the First Affiliated Hospital of Soochow University,
                                   1
                                          6
                      1
          Jiangsu  Suzhou  215006,  China;2.  Dept.  of  Pharmacy,  the  Fifth  Affiliated  Hospital  of  Zhengzhou  University,
          Zhengzhou  450052,China;3.  Dept.  of  Pharmacy,  Zhaoqing  First  People’s  Hospital,  Guangdong  Zhaoqing
          526000, China;4. Dept. of Pharmacy, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou
          450007,  China;5.  Dept.  of  Pharmacy,  the Affiliated  Huaian  No.1  People’s  Hospital,  Jiangsu  Huaian  223300,
          China;6.  Dept.  of  Nephrology,  the  First  Affiliated  Hospital  of  Soochow  University,  Jiangsu  Suzhou  215006,
          China;7. Dept. of Pharmacy, Guiyang Maternal and Child Health Care Hospital, Guiyang 550003, China)
          ABSTRACT    OBJECTIVE  To  develop  a  whole-process  intelligent  model  of  pharmaceutical  care  for  peritoneal  dialysis (PD)
          patients,  and  to  provide  a  reference  for  clinical  pharmacists  to  provide  standardized  PD  pharmaceutical  care.  METHODS  The
          pharmaceutical  care  mode  of  PD  patients  at  home  and  abroad  was  investigated  and  analyzed.  Based  on  the  actual  situation  of  the
          First Affiliated  Hospital  of  Soochow  University (hereinafter  referred  to  as “our  hospital”),  with “home→PD  center  outpatient→
          inpatient  department”  as  the  main  node,  the  recycling  process  of  medication  reconciliation  was  optimized.  The  whole-process
          intelligent pharmaceutical care model of PD was illustrated by improving the Chinese version of the drug-related problems (DRPs)
          classification  tool,  developing  the  corresponding  pharmaceutical  care  process,  and  presenting  specific  cases.  RESULTS  Based  on
          the  medication  therapy  management (MTM)  platform,  our  hospital  had  built  a  closed-loop  PD  whole-process  intelligent
          pharmaceutical care model of “in-hospital pharmaceutical care (building document)-PD outpatient MTM-home pharmaceutical care
         (online App management)”. A “double cycle” workflow of “admission→discharge→outpatient” medication reconciliation cycle and
         “discovery-analysis-intervention-follow-up-record-evaluation”  DRPs  cycle  was  formed.  CONCLUSIONS  The  establishment  of  the
                                                              whole-process  intelligent  pharmaceutical  care  model  for  PD  in
              Δ 基金项目 江苏省医学重点学科项目(No.ZDXK202247);苏州
                                                              our   hospital   provides   experience   for   standardizing
          市科技发展计划指导性项目(No.SKYXD2022017);江苏省药学会——
                                                              pharmaceutical care for PD patients, and can reduce DRPs.
          恒瑞医院药学基金项目(No.H202032)
             *第一作者 副主任药师,硕士。研究方向:临床药学。电话:                     KEYWORDS    peritoneal  dialysis;  pharmaceutical  care;  work
          0512-67973021。E-mail:hangyongfu1986@163.com         model;  clinical  pharmacist;  medication  reconciliation;  drug-
              #  通信作者 副主任护师。研究方向:腹膜透析专科护理。                    related problems; medication therapy management
          E-mail:1641323553@qq.com


          · 2644 ·    China Pharmacy  2023 Vol. 34  No. 21                            中国药房  2023年第34卷第21期
   89   90   91   92   93   94   95   96   97   98   99